Skip Navigation
National Cancer Institute

Smoking Cessation within the Context of Lung Cancer Screening Awards Announced

The National Cancer Institute (NCI) has awarded six grants to support research on the design and implementation of smoking cessation interventions in lung cancer screening settings (RFA-CA-15-011). NCI plans to provide a total of $18.4 million to support the projects for five years. In 2013, the United States Preventive Services Task Force recommended adults ages 55-80 with a 30 pack-year smoking history (who currently smoke or have quit in the past 15 years) undergo annual low-dose computed tomography (LDCT) lung cancer screening. Smoking cessation treatment during LDCT screening offers great potential to reduce tobacco use rates and smoking-related morbidity and mortality. Smoking and exposure to tobacco smoke cause more than 440,000 premature deaths from cancer, heart disease, stroke, and lung disease in the United States each year.
Awardees Are:

The newly funded grants will advance scientific understanding of the components and characteristics of effective smoking cessation interventions in the lung cancer screening setting, and will provide models for the implementation of evidence-based cessation interventions in screening settings across the nation.
For more information about the Tobacco Control Research Branch, within the NCI Behavioral Research Program, visit: https://cancercontrol.cancer.gov/brp/tcrb/.

Visit the archive page to view other Scientific News from the Behavioral Research Program newsletters.